Connect with us

News

Red Deer County Patrol Issues Safe Driving Reminder

Published

1 minute read

By Sheldon Spackman

Red Deer County Protective Services has issued a reminder for residents to drive safe. This, after the release this week of the County’s Patrol statistics from 2016.

Those stats indicate 72 percent of traffic infractions last year were speeding tickets. The greatest speed over the posted speed limit was 167 km/h in an 80 zone, while the highest speed recorded was 173 km/h in a 90 zone.

Officials say nine percent of 2016 traffic tickets in Red Deer County were for commercial vehicle infractions, while five percent were for none use of seatbelts. Another five percent were for unregistered vehicles and four percent for intersection violations. A further two percent each were for distracted drivers and unlicensed drivers, while the last one percent were for uninsured vehicles.

Follow Author

Top Story CP

CFL leaves door open for Argos' quarterback Bethel-Thompson playing in East final

Published on

TORONTO — The CFL has left the door open to McLeod Bethel-Thompson playing in the East Division final Sunday.

The Toronto Argonauts starting quarterback was held out of practice and sent home Friday after attending the Toronto Raptors 97-93 home win over the Milwaukee Bucks on Thursday night.

That violated the CFL’s COVID-19 protocol, which would’ve normally meant Bethel-Thompson having to quarantine for four days and provide two negative tests before being able to resume team activities.

But Toronto hosts the Hamilton Tiger-Cats in the conference final Sunday afternoon at BMO Field.

The CFL announced Friday afternoon Bethel-Thompson will be allowed to play Sunday if he produces negative COVID testing following a 48-hour quarantine at his residence.

Argos Dexter McCoil, Charleston Hughes, Llevi Noel and Jeff Richards also attended the basketball game and will be subject to the same requirements as Bethel-Thompson.

Toronto (9-5) finished atop the East Division standings to secure home-field advantage for the conference final.

Bethel-Thompson was 7-2 as Toronto’s starter this season.

Both the Argos and Raptors are owned by Maple Leafs Sports & Entertainment.

If Bethel-Thompson can’t play, Antonio Pipkin will start for Toronto on Sunday.

The six-foot-three, 225-pound Pipkin started Toronto’s season-ending 13-7 home loss to Edmonton on Nov. 16, completing 10-of-22 passes for 111 yards and an interception while rushing for 78 yards and a TD on nine carries.

Video of Bethel-Thompson holding his infant daughter at the NBA game was carried on the Argos’ Twitter account Thursday night but was no longer available Friday.

But it was present long enough for Hamilton receiver Brandon Banks to notice.

“Wow when I tried to go to raptors game the @cfl told me I couldn’t go!” Banks tweeted. “I ain’t snitching but shit fishy ! #Protocol #tier1.”

Bethel-Thompson also appeared on TSN’s broadcast of the Raptors-Bucks game.

TSN is the CFL’s broadcast partner.

“So lemme get this straight,” TSN’s Kayla Grey, who interviewed Bethel-Thompson during the broadcast, tweeted Friday. ” … a starting quarterback goes on a national broadcast to promote an East Final that he is now forced to miss because the league is forcing him to quarantine for going to a game to promote said East Final?

“Baby what a mess.”

This report by The Canadian Press was first published Dec. 3, 2021.

The Canadian Press

Continue Reading

Top Story CP

Canada buying up to 1.5 million courses of oral antiviral drugs to fight COVID-19

Published on

OTTAWA — Procurement Minister Filomena Tassi says Canada has signed agreements to buy up 1.5 million courses of oral antiviral treatment for COVID-19.

The government has signed up for an initial one million courses of antiviral treatment, once Health Canada endorses their safety and efficacy.

Pfizer submitted a request for Health Canada approval earlier this week.

Canada has also purchased 500,000 courses of Merck’s oral antiviral treatment for COVID-19, with the option to purchase another 500,000 once Health Canada approves the drug.

The drugs are designed to block the enzyme essential for viral replication.

Merck’s clinical trial showed a 50 per cent reduced risk of hospitalization or death compared to placebo patients with mild or moderate COVID-19.

This report by The Canadian Press was first published Dec. 3, 2021.

The Canadian Press

Continue Reading

Trending

X